Key facts
- Chipiron’s last known valuation is $67.9M (Apr 2025).
- It has raised $26.9M; the latest was Later Stage VC ($16.6M) in Apr 2025.
- Notable investors include Bpifrance, European Innovation Council, Entrepreneurs First, Agoranov, Unruly Capital — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Chipiron
- ·The full record, as it builds
Funding rounds
No funding rounds for Chipiron are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chipiron
Developer of a portable MRI machine technology designed to produce three-dimensional, detailed anatomical images. The company uses quantum sensors to produce images for disease detection, diagnosis, and treatment monitoring, enabling healthcare institutions to decrease the fatality rate of brain-related diseases.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2020
- Employees
- 48
- Website
- chipiron.co/
- Ownership
- Privately Held (backing)
Chipiron doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chipiron shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chipiron in its N-PORT filings yet. We sweep new filings monthly.